Imaginatik Investor News

News for investors in Imaginatik plc

Archive for May, 2009

Shares Magazine: Imaginatik – Blue Sky Stocks

Posted by markturrell on May 18, 2009

Shares MagazineDownload PDF: Imaginatik in Shares Magazine 140509

Shares Magazine – article online here

 

Published date:

 Thursday, May 14, 2009

Everyone loves the idea of a blue-sky punt. It is an investor’s dream to pick up a tiny stock for pennies, maybe a loss-making company beavering away with a brilliant idea, and then watch as its ideas and products catch on, start-up losses turn into huge profits and the stock rises tenfold or more, making you a fortune. The odds against are high but it can and does happen. Under the guidance of Robin Saxby, ARM Holdings (ARM) revolutionised the global silicon chip industry when it developed the fabless and chipless semiconductor model. This means company does not get involved in the difficult and expensive process of silicon chip manufacturing. Instead, it licenses out its processor architectures for a fee and then collects a royalty each time a chip featuring its designs is manufactured. Nineteen years after ARM was spun out of the ultimately-doomed computer company Acorn, the firm still dominates the semiconductor intellectual property (semi IP) market. Following its 1998 initial public offering the shares flew up by 2,320% in their first two years of trading, rewarding those investors who backed the ARM management team’s technological prowess as well as their vision.

Jam tomorrow

Many investors shun the risk involved when buying ‘jam tomorrow’ stocks, which promise huge profits in three, four or five year’s time but in the end often fail to deliver. In his book of 2003, ‘The Innovator’s Solution’, business guru and Harvard Professor Clayton Christensen wrote: ‘Over 60% of all new-product development efforts are scuttled before they ever reach the market. Of the 40% that see the light of day, 40% fail to become profitable and are withdrawn from the market’.

That means just a quarter actually make it to the big time and this risk has to be taken into account when looking for the next Microsoft or Nokia – both of which, it must not be forgotten, had humble origins, in Bill Gates’ garage and as a loss-making Finnish engineering-to-consumer-electronics respectively.

It may seem ever more foolhardy to be looking for blue-sky stocks in the teeth of a recession. But any firm capable of generating earnings growth whatever the economic environment will always be a highly-prized asset. The recent market recovery, which has seen the FTSE All-Share surge into positive territory for 2009, has also seen investors’ once more show an appetite for risk and a willingness to take a chance on a stock making it big. The market plunge seen since 2007 also means many ‘jam tomorrow’ stocks have seen their share prices pounded and market valuations collapse, as investors fled risk and proved particularly wary of smaller firms which were struggling to fund their short-term investment needs. Once-promising prospects such as embedded computer specialist Inova, hand-held device maker i-mate and storage specialist Plasmon have suffered either huge share price collapses or decided to delist or simply failed altogether.

Yet many budding British investment stars are doing just fine, thank you and after two years of stock market falls they could now prove bargain investments.

The rewards

Technology is the area where most investors will look for the next ten-bagger. ARM is certainly sitting pretty with its chips present in 98% of all of the world’s mobile phones, and in spite of the recession putting a damper on the party this is not a product likely to go out of fashion any time soon. Pace (PIC) has seen shares rally nearly 300% this year alone as the manufacturer of digital TV set-top boxes is benefiting from the digital switch-over. Investors should therefore look for punts whose products are easy to use, offer a huge improvement in terms of productivity or quality of service against the

current incumbent product and give the firm a chance to generate high profit margins once past the start-up phase so it can monetise its first-mover advantage.

But there are other parts of the equity market which can also offer money spinning

success stories. Back in 1992 Cairn Energy (CNE) was just another struggling Scottish prospector for oil and gas in the North Sea and Texas, with a few rigs going nowhere fast. A discovery in Rajasthan, Northern India, looked more promising but 50% partner Shell was not convinced. Ten years on, Cairn took the plunge and bought Shell out for £7 million and stepped up its drilling. The rest, as they say, is history. Cairn is now firmly established as a FTSE 100 firm, with oil assets in India, Bangladesh and Nepal and a market cap of £3.2 billion. Those shrewd enough to back the judgement of Sir Bill Gammell, who founded Cairn and was appointed chief executive officer when the firm floated in 1988, have been rewarded with a rise in Cairn’s share price from 193p to £23.48 and a 1,117% return in just over 20 years.

The risks

Running out of money is a common problem for start-up firms which often have to carry heavy research and development (R&D) costs before they generate any sales, let alone any profits. Following an abandoned takeover bid, semiconductor equipment production expert Bede had to call in administrators last year after failing to secure new funding in its efforts to establish industry support for its innovative X-Ray metrology products, despite the presence of industry heavy-hitter Stuart McIntosh on its board. Cash woes, end market volatility and a collapsing share price prompted computer components maker OCZ Technology to leave Aim last month in preference for a US listing. Investors looking for punts must therefore be mindful of companies’ cash burn, and whether their financing, or preferably cash, will keep them afloat through to profitability even if things go according to plan.

Inventing a product that changes or creates a market can be very profitable, presuming customers can be persuaded that they need it – and are willing to pay for it. Eleksen’s failed attempt to develop electronic gadget controls out of fabric proved this point, while Servocell ran out of cash before it could persuade the world its Active Latch electronic locking mechanism really was superior to its traditional electromechanical rivals.

Spotting the winners

‘You need to be extremely mindful of where it can go wrong. If you do that the upside will take care of itself,’ says Justin Jordan, fund manager at Credit Suisse. He points to three characteristics to look for in a growth stock: ‘A company with a niche product or service which means it can grow its earnings faster than the market over a number of years. A company which delivers earnings upgrades. A company and a management team that is being re-rated by the market over time.’

In his final point Jordan addresses the thorny issue of valuation. ARM and unstructured data management specialist Autonomy (AU.) have been fabulous success stories and look set to dominate their respective industries for years to come. Yet neither share is trading within a country mile of the highs seen in 2000 before the technology bubble burst. At 111p ARM stands 90% below its December 1999 bubble high of £10.01 and at £14.59 Autonomy is still way below its November 2000 peak of £34.27, even though both have sales and profits higher than they were nine years ago.

This is because any valuation mechanism has two parts. In the case of the PE it is ‘E’ for earnings for ‘P’ for the price, or multiple, investors are willing to pay to get access to those earnings. After the tech disappointments of 2000-2001, when lofty growth expectations were not met, investors are simply attaching a lower valuation, or ‘Price’, to each company’s earnings stream and cash flow to reflect the risks involved. The shares are said to have suffered a ‘de-rating’ as a result. If the reverse happens – earnings keep surprising on the upside – the stock is perceived as being less risky and it will enjoy the ‘re-rating’ flagged by Credit Suisse’s Jordan.

It is in cases such as these that fortune favours the bold as hype is followed by substance. A strong management team, a product that makes sense, and funding to reach profitability are good places to start. To help investors spot the stars and dodge the duds Shares has analysed five industries which are capable of witnessing the emergence of a new market leader and also highlighted the potential of ten individual firms.

[Note - only included Imaginatik content - more at the Shares web site]

Imaginatik (IMTK:AIM)

Market cap: £6.3 million

Share price: 4.75p

Imaginatik’s collaborative innovation software enables businesses to tap into talent and ideas that otherwise would have been missed. The method both improves processes and saves money for clients, which include a string of international blue-chips. Existing clients reported £170 million in cost reductions over the past two years. This year has seen a string of contract wins across sectors for Imaginatik, and house broker WH Ireland expects 2009 to be the year of maiden profits. (JF)

Posted in Imaginatik, Investor Press, imtk, innovation | 1 Comment »

Shares: Boardroom Bonanza – directors who correctly called the markets – Imaginatik CEO, Mark Turrell, in Top 10

Posted by markturrell on May 11, 2009

Shares Magazine: Boardroom Bonanza

Published date:

 Thursday, May 7, 2009

Directors know their company like no outsider could ever hope to. But not all of them are good at timing their investments in their own shares. That is why Shares has spent the past year tracking all the major director deals in a huge database to identify the board members worth following.

After recording the key buys and sells we can exclusively reveal who has their finger on the pulse. The top ten performing trades (see table, page 21), have delivered gains of between 211% and 486%. We unearth the motivations behind the deals and lessons to be learnt. Interestingly all of the top ten trades have been purchases made since November with a good number seeing management correctly believing their firms would return from the brink of a debt crisis.

A modest £50,403 acquisition by Wolseley (WOS) chief executive Claude Hornsby was the stand-out call. Made ten days after the builders merchant unveiled a £1 billion cash call, via a rights issue and placing, the 53-year-old correctly took the view a very depressed share price of 202p would quickly rebound as debt fears eased. In a little over a month shares have risen almost six-fold to £11.82, generating Hornsby a bumper 486% return.

Likewise, Davenham’s (DAV:AIM) risk director David Bowles (the eighth highest gain with a buy generating 224%) correctly put his money down in the belief the specialist lender would succeed in refinancing £215 million of banking facilities. Meanwhile, Simon Embley, chief executive of LSL Property Services (LSL) bought last November at 32p, a historic low for the company, as it extended debt facilities to 2011. This trade has since generated 225%, the seventh best return.

Four of the top ten performing directors bought on more than one occasion allowing us to build up a complete picture of their dealing track record. One lesson from this is that directors, like all investors, have trouble timing the bottom. David Radcliffe, chief executive of travel services group Hogg Robinson (HRG) started buying at 11.4p in early December ahead of the hugely profitable purchase at 4p later that month which has since returned 445% and secured him the accolade of the second-best trade.

Likewise, Cryo-Save (CRYO:AIM) non-executive Johan Goossens is 18% down on an early buy of 100,000 shares in September at 71p. But set against three profitable subsequent purchases between 12p and 38p, for a combined £214,300 consideration, the co-founder of the stem cell storage specialist clearly has a better feel for his company’s worth than the market, with his 12p deal now 383% in the money at today’s 58p.

Among our top-ten performing directors we would be cautious of following Imaginatik’s (IMTK:AIM) chief executive Mark Turrell. Contract wins have given credibility to forecasts of maiden operating profit and mean Turrell’s seven purchases last year at between 1.9p and 5.3p per share are in the black. But seven subsequent acquisitions since 2 January have lost him money tarnishing his overall performance.

The ten worst trades of the past year have generated losses of between 46% and 102%, with a sale by Maple Energy (MPLE:AIM) chief executive Rex Canon, at 109p, topping the table. Investors should note it is always harder to read anything into directors’ sales than in it purchases, as there can be many more reasons related to an individual’s circumstances driving a disposal. In Canon’s case it should be remembered the 47-year-old still retains a sizeable 8.9% stake in the business.

Xstrata’s (XTA) chief executive Mick Davis, whose two giant trades of the past 12 months have generated both the biggest monetary gain (£2.6 million) and the second largest monetary loss (£6.1 million), is clearly, net net, a poor indicator of where his company’s shares will go next. The losing trade also secured him number two position in our table of the least profitable deals with a purchase at £41.51 last May, currently down 88%.

Jorge Cosmen, deputy chairman of transport group National Express (NEX), should be used a contrarian signal for watchers of the transport group. His £26.3 million purchase at 870p last May, has since depreciated by 70%, or £18.4 million, and stands out as the worst monetary loss of the past 12 months. But he also bought a further three times and all have been losing trades bringing his total losses for the year to £27.1 million.

Director buying or selling can be a useful signal for outsiders. But it is vital investors consider the subject’s track record as well as fundamental analysis of a firm’s business, strategy and financial performance. Having recorded every single director deal over the past year Shares is in a good position to tell investors who is worth following and who is not.

…..

Top 10 best transactions by percentage gains

# 10. Mark Turrell 211% gain - Imaginatik (IMTK:AIM)

Turrell, 38, co-founded Imaginatik in 1994. Combined with his experience from Intel and General Motors, his doctoral thesis on collaboration and knowledge management became the basis for his business.

Chief executive Turrell’s vote of confidence drew a line under the falling share price last December, as he bought 55,000 shares at the 1.9p year low. The software company, which offers tools for collaborative problem solving, saw shares fall sharply the preceding October despite its cautiously optimistic trading update, as the market lost its tolerance for companies not yet profitable. Turrell bought another 75,550 shares in January, at 6p to 7.5p, only to see the stock fall back to 4.8p. But with several recent contract wins, the £6.3 million cap expects this year to mark its first operating profit. (JF)

 

See PDF of scanned article – Shares_Imaginatik_May09

 

Posted in Imaginatik, Investor Press, imtk | Leave a Comment »

Techinvest: “trading in line with expectations… maiden profit”

Posted by markturrell on May 11, 2009

Imaginatik      4.75p

(IMTK: AIM, Tech Software & Services)

The Company has signed a contract extension with long-standing customer, Pfizer. The agreement will ensure the long-term ongoing use of Imaginatik’s Idea Central software within Pfizer’s Research and Development division. The Company also announced that results for the year to March 31 will be in line with expectations and a maiden operating profit is anticipated for the period.

Analyst George O’Connor at Broker Panmure Gordon commented during the month that Imaginatik is a company with plenty of upside potential and management that “looks in their stride”.

Continue to hold. 

Source: Techninvest, Fri 1 May 2009

Posted in Imaginatik, Investor Press, imtk | Leave a Comment »